CareLit · DOI-Nachweis · Pneumologie
The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Instititial Lung Diseases: Subgroup with Autoimmune Diseases*
DOI 10.1055/s-0039-3403189
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Bonella, E Matteson, C Kelly, JHW Distler, A Hoffmann-Vold, JR Seibold, S Mittoo, O Distler, RG Goeldner, R Schlenker-Herceg, S Stowasser, M Quaresma, KR Flaherty
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Instititial Lung Diseases: Subgroup with Autoimmune Diseases*
Zitieren
Zitierempfehlung
F Bonella, E Matteson, C Kelly, JHW Distler, A Hoffmann-Vold, JR Seibold, S Mittoo, O Distler, RG Goeldner, R Schlenker-Herceg, S Stowasser, M Quaresma, KR Flaherty (2020) The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Instititial Lung Diseases: Subgroup with Autoimmune Diseases*. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403189
Mit CareLit weiterarbeiten